Ye Edward Tian
Directeur Technique/Scientifique/R&D chez IMPACT Therapeutics, Inc.
Provenance du réseau au premier degré de Ye Edward Tian
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China.
1
| Holding Company | Pharmaceuticals: Generic | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ye Edward Tian via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BiTech Pharma, Inc.
 BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Chairman | |
| The University of Chicago | College/University | Masters Business Admin | |
| University of Kansas | College/University | Doctorate Degree | |
| Shandong University | College/University | Undergraduate Degree | |
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | ||
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 8 |
| Chine | 4 |
| Îles Cayman | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 4 |
| Consumer Non-Durables | 2 |
| Commercial Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Director/Board Member | 2 |
| Chairman | 1 |
| Independent Dir/Board Member | 1 |
| Chief Executive Officer | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jun Bao | 12 |
- Bourse
- Insiders
- Ye Edward Tian
- Connexions Sociétés
